MXPA02011560A - Microesferas de liberacion prolongada para suministro por inyeccion y metodo de preparacion. - Google Patents
Microesferas de liberacion prolongada para suministro por inyeccion y metodo de preparacion.Info
- Publication number
- MXPA02011560A MXPA02011560A MXPA02011560A MXPA02011560A MXPA02011560A MX PA02011560 A MXPA02011560 A MX PA02011560A MX PA02011560 A MXPA02011560 A MX PA02011560A MX PA02011560 A MXPA02011560 A MX PA02011560A MX PA02011560 A MXPA02011560 A MX PA02011560A
- Authority
- MX
- Mexico
- Prior art keywords
- active principle
- preparation
- injection delivery
- prolonged release
- release microspheres
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0006587A FR2809309B1 (fr) | 2000-05-23 | 2000-05-23 | Microspheres a liberation prolongee pour administration injectable |
PCT/FR2001/001575 WO2001089481A1 (fr) | 2000-05-23 | 2001-05-22 | Microspheres a liberation prolongee pour administration injectable et procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02011560A true MXPA02011560A (es) | 2004-09-10 |
Family
ID=8850528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02011560A MXPA02011560A (es) | 2000-05-23 | 2001-05-22 | Microesferas de liberacion prolongada para suministro por inyeccion y metodo de preparacion. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040043076A1 (no) |
EP (1) | EP1303259B1 (no) |
JP (1) | JP2003534267A (no) |
KR (1) | KR100787669B1 (no) |
CN (1) | CN1438877A (no) |
AR (1) | AR029667A1 (no) |
AU (2) | AU6399601A (no) |
BR (1) | BR0111054A (no) |
CA (1) | CA2410219A1 (no) |
ES (1) | ES2413406T3 (no) |
FR (1) | FR2809309B1 (no) |
HU (1) | HU228702B1 (no) |
IL (2) | IL153046A0 (no) |
MX (1) | MXPA02011560A (no) |
NO (1) | NO333742B1 (no) |
TW (1) | TWI264310B (no) |
WO (1) | WO2001089481A1 (no) |
ZA (1) | ZA200209553B (no) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
DE60109701T2 (de) | 2000-10-10 | 2006-03-09 | Kao Corp. | Verfahren zur Herstellung von Verbundpartikeln |
ES2326209T3 (es) | 2000-10-27 | 2009-10-05 | Baxter Healthcare S.A. | Produccion de microesferas. |
US20080026068A1 (en) * | 2001-08-16 | 2008-01-31 | Baxter Healthcare S.A. | Pulmonary delivery of spherical insulin microparticles |
US20030064033A1 (en) * | 2001-08-16 | 2003-04-03 | Brown Larry R. | Propellant-based microparticle formulations |
GB0205868D0 (en) * | 2002-03-13 | 2002-04-24 | Univ Nottingham | Polymer composite with internally distributed deposition matter |
US20070092452A1 (en) * | 2003-07-18 | 2007-04-26 | Julia Rashba-Step | Methods for fabrication, uses, compositions of inhalable spherical particles |
US20050142205A1 (en) * | 2003-07-18 | 2005-06-30 | Julia Rashba-Step | Methods for encapsulating small spherical particles prepared by controlled phase separation |
JP2007531701A (ja) * | 2003-07-18 | 2007-11-08 | バクスター・インターナショナル・インコーポレイテッド | 制御された相分離により調製される小球状粒子の作製方法、使用および組成物 |
CA2532874A1 (en) * | 2003-07-22 | 2005-02-03 | Baxter International Inc. | Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof |
EP1659918B1 (en) | 2003-08-08 | 2009-01-14 | Amgen Fremont Inc. | Antibodies directed to parathyroid hormone (pth) and uses thereof |
US7318925B2 (en) * | 2003-08-08 | 2008-01-15 | Amgen Fremont, Inc. | Methods of use for antibodies against parathyroid hormone |
KR100603974B1 (ko) * | 2003-12-05 | 2006-07-25 | 김갑식 | 고체상 지질을 용매로 이용한 나노수준의 또는 비결정질입자의 제조 방법 |
FR2868704B1 (fr) * | 2004-04-07 | 2007-09-14 | Ethypharm Sa | Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires |
DK1758558T3 (da) * | 2004-05-12 | 2014-01-20 | Baxter Int | Oligonukleotidholdige mikrokugler samt deres anvendelse til fremstilling af et medikament til behandling af diabetes type 1 |
MXPA06012992A (es) * | 2004-05-12 | 2007-02-12 | Baxter Int | Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente. |
US8728525B2 (en) * | 2004-05-12 | 2014-05-20 | Baxter International Inc. | Protein microspheres retaining pharmacokinetic and pharmacodynamic properties |
ES2313350T3 (es) * | 2004-05-12 | 2009-03-01 | Baxter International Inc. | Microesferas de acido nucleico, produccion y suministro de las mismas. |
US7390097B2 (en) * | 2004-08-23 | 2008-06-24 | 3M Innovative Properties Company | Multiple channel illumination system |
FR2874836B1 (fr) * | 2004-09-09 | 2007-04-27 | Pierre Fabre Medicament Sa | Procede d'enrobage de poudres |
JPWO2006057374A1 (ja) * | 2004-11-29 | 2008-06-05 | 独立行政法人科学技術振興機構 | 複合微粒子の製造方法 |
AU2006241145B2 (en) * | 2005-04-27 | 2011-04-28 | Baxter Healthcare S. A. | Surface-modified microparticles and methods of forming and using the same |
WO2007009164A1 (en) * | 2005-07-15 | 2007-01-25 | Eiffel Technologies Limited | Method of particle formation |
CN103462943A (zh) * | 2005-07-15 | 2013-12-25 | Map药物公司 | 在离散的吸入粒子中结合的多种活性药物成分及其制剂 |
US20070281031A1 (en) * | 2006-06-01 | 2007-12-06 | Guohan Yang | Microparticles and methods for production thereof |
AU2007281737B2 (en) * | 2006-08-04 | 2013-09-19 | Baxter Healthcare S.A. | Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
WO2008060786A2 (en) * | 2006-10-06 | 2008-05-22 | Baxter International Inc. | Microencapsules containing surface-modified microparticles and methods of forming and using the same |
AU2008242842B2 (en) * | 2007-04-17 | 2014-06-05 | Baxter Healthcare Sa | Nucleic acid microparticles for pulmonary delivery |
DK2170283T3 (en) | 2007-06-22 | 2019-04-15 | Univ Texas | CREATION OF STABLE SUBMICRON Peptide OR PROTEIN PARTICLES BY THIN FILM FREEZING |
GB0812742D0 (en) * | 2008-07-11 | 2008-08-20 | Critical Pharmaceuticals Ltd | Process |
US8323615B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing multi-phasic dispersions |
US20100047292A1 (en) * | 2008-08-20 | 2010-02-25 | Baxter International Inc. | Methods of processing microparticles and compositions produced thereby |
US8367427B2 (en) * | 2008-08-20 | 2013-02-05 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US8323685B2 (en) * | 2008-08-20 | 2012-12-04 | Baxter International Inc. | Methods of processing compositions containing microparticles |
US8779094B2 (en) * | 2008-11-16 | 2014-07-15 | Board Of Regents, The University Of Texas System | Low viscosity highly concentrated suspensions |
US20100291221A1 (en) * | 2009-05-15 | 2010-11-18 | Robert Owen Cook | Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation |
EP2353588B1 (en) * | 2010-01-21 | 2015-04-15 | Agricultural Technology Research Institute | A sustained release preparation of factor IX |
KR101156094B1 (ko) * | 2010-02-22 | 2012-06-20 | 경상대학교산학협력단 | 약물송달을 위한 양친성 PHA-mPEG 공중합 나노 컨테이너 |
IL277958B2 (en) * | 2011-11-18 | 2023-11-01 | Regeneron Pharma | Micro-particles of polymeric proteins |
CN102552169B (zh) * | 2012-02-17 | 2015-07-29 | 深圳市健元医药科技有限公司 | 一种醋酸阿肽地尔缓释微球制剂及其制备方法 |
KR101421343B1 (ko) | 2012-08-21 | 2014-07-18 | 경상대학교산학협력단 | 폴리(4-하이드록시부티레이트)-b-모노메톡시(폴리에틸렌글리콜) 공중합체 나노입자, 이의 제조방법 및 이를 유효성분으로 함유하는 뇌질환 치료용 약학적 조성물 |
WO2014051251A1 (en) * | 2012-09-28 | 2014-04-03 | Industrial Cooperation Foundation Chonbuk National University | Pvax copolymer and pvax microparticles comprising the same |
CN102921011B (zh) * | 2012-11-09 | 2014-10-15 | 东华大学 | 一种仿血细胞形貌温敏聚合物微球及其制备方法 |
GB201317756D0 (en) * | 2013-10-08 | 2013-11-20 | Critical Pharmaceuticals Ltd | New process |
JP6247400B2 (ja) * | 2013-12-31 | 2017-12-13 | ペベエベ・エスア | 身体再建及び身体成形における使用のための制御放出脂肪酸組成物 |
CN104474533A (zh) * | 2014-11-24 | 2015-04-01 | 华南理工大学 | 一种可用于创面修复的复合微球的制备方法 |
US9375478B1 (en) | 2015-01-30 | 2016-06-28 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
CN108042793B (zh) * | 2017-11-13 | 2020-07-07 | 中国人民解放军第四军医大学 | 包埋gdnf的多核-单壳微球缓释系统的制备方法 |
CN110882232A (zh) * | 2018-08-20 | 2020-03-17 | 中国科学院过程工程研究所 | 一种基于微囊的疫苗 |
CN110585055B (zh) * | 2019-08-26 | 2023-06-13 | 武汉贝缇安卡医疗健康投资有限公司 | AcSDKP在增加成纤维细胞分泌Ⅲ型胶原蛋白含量的应用 |
CN114209887B (zh) * | 2021-08-24 | 2023-03-03 | 杭州协合医疗用品有限公司 | 一种含可控降解聚酯微球的注射用凝胶 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3777721D1 (de) * | 1986-08-11 | 1992-04-30 | American Cyanamid Co | Zusammensetzungen zur parenteralen verabreichung und deren verwendung. |
EP0706821A1 (en) * | 1994-10-06 | 1996-04-17 | Centre De Microencapsulation | Method of coating particles |
WO1996028143A1 (de) * | 1995-03-10 | 1996-09-19 | Boehringer Mannheim Gmbh | Polypeptid-enthaltende pharmazeutische darreichungsformen in form von mikropartikeln und verfahren zu deren herstellung |
FR2753639B1 (fr) * | 1996-09-25 | 1998-12-11 | Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede | |
US5766637A (en) * | 1996-10-08 | 1998-06-16 | University Of Delaware | Microencapsulation process using supercritical fluids |
CA2277801C (en) * | 1997-01-16 | 2002-10-15 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
WO2000004916A1 (en) * | 1998-07-23 | 2000-02-03 | Societe De Conseils De Recherches Et D'applications Scientifiques Sas | Encapsulation of water soluble peptides |
ES2289823T3 (es) * | 1998-08-25 | 2008-02-01 | Advanced Inhalation Research, Inc. | Formulaciones proteicas estables secadas por atomizacion. |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
FR2797398B1 (fr) * | 1999-08-11 | 2002-10-18 | Mainelab | Microparticules pour administration pulmonaire |
EP1242112A4 (en) * | 1999-12-21 | 2005-02-09 | Rxkinetix Inc | PRODUCTS CONTAINING MEDICINANT SUBSTANCE PARTICLES AND PROCESS FOR PREPARING THE SAME |
DE60141680D1 (de) * | 2000-01-14 | 2010-05-12 | Univ Brown Res Found | Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln |
DK1280520T4 (en) * | 2000-05-10 | 2018-06-25 | Novartis Ag | Phospholipid based powders for drug delivery |
-
2000
- 2000-05-23 FR FR0006587A patent/FR2809309B1/fr not_active Expired - Lifetime
-
2001
- 2001-05-22 WO PCT/FR2001/001575 patent/WO2001089481A1/fr active IP Right Grant
- 2001-05-22 EP EP01938300A patent/EP1303259B1/fr not_active Expired - Lifetime
- 2001-05-22 IL IL15304601A patent/IL153046A0/xx unknown
- 2001-05-22 CN CN01809902A patent/CN1438877A/zh active Pending
- 2001-05-22 HU HU0302012A patent/HU228702B1/hu not_active IP Right Cessation
- 2001-05-22 KR KR1020027015881A patent/KR100787669B1/ko not_active IP Right Cessation
- 2001-05-22 JP JP2001585726A patent/JP2003534267A/ja active Pending
- 2001-05-22 CA CA002410219A patent/CA2410219A1/fr not_active Abandoned
- 2001-05-22 AU AU6399601A patent/AU6399601A/xx active Pending
- 2001-05-22 ES ES01938300T patent/ES2413406T3/es not_active Expired - Lifetime
- 2001-05-22 US US10/296,314 patent/US20040043076A1/en not_active Abandoned
- 2001-05-22 MX MXPA02011560A patent/MXPA02011560A/es not_active Application Discontinuation
- 2001-05-22 AU AU2001263996A patent/AU2001263996B2/en not_active Ceased
- 2001-05-22 BR BR0111054-3A patent/BR0111054A/pt not_active Application Discontinuation
- 2001-05-23 AR ARP010102466A patent/AR029667A1/es not_active Application Discontinuation
- 2001-07-18 TW TW090112316A patent/TWI264310B/zh not_active IP Right Cessation
-
2002
- 2002-11-19 NO NO20025552A patent/NO333742B1/no not_active IP Right Cessation
- 2002-11-24 IL IL153046A patent/IL153046A/en active IP Right Grant
- 2002-11-25 ZA ZA200209553A patent/ZA200209553B/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0302012A3 (en) | 2005-11-28 |
FR2809309A1 (fr) | 2001-11-30 |
IL153046A0 (en) | 2003-06-24 |
BR0111054A (pt) | 2003-04-15 |
US20040043076A1 (en) | 2004-03-04 |
JP2003534267A (ja) | 2003-11-18 |
AU6399601A (en) | 2001-12-03 |
AR029667A1 (es) | 2003-07-10 |
ZA200209553B (en) | 2003-08-26 |
EP1303259A1 (fr) | 2003-04-23 |
NO333742B1 (no) | 2013-09-02 |
NO20025552D0 (no) | 2002-11-19 |
KR100787669B1 (ko) | 2007-12-21 |
CA2410219A1 (fr) | 2001-11-29 |
AU2001263996B2 (en) | 2006-01-19 |
HU228702B1 (en) | 2013-05-28 |
NO20025552L (no) | 2003-01-20 |
IL153046A (en) | 2013-12-31 |
FR2809309B1 (fr) | 2004-06-11 |
KR20030011858A (ko) | 2003-02-11 |
HUP0302012A2 (hu) | 2003-09-29 |
ES2413406T3 (es) | 2013-07-16 |
WO2001089481A1 (fr) | 2001-11-29 |
EP1303259B1 (fr) | 2013-03-20 |
TWI264310B (en) | 2006-10-21 |
CN1438877A (zh) | 2003-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA02011560A (es) | Microesferas de liberacion prolongada para suministro por inyeccion y metodo de preparacion. | |
DE60202971D1 (de) | Betätigungskappe für eine sprühdose | |
ATE245022T1 (de) | Verfahren zur herstellung von mikropartikeln | |
NO962994D0 (no) | Framgangsmåte for framstilling av hule mikrosfærer | |
AR048017A1 (es) | Composicion y metodo para aumentar la biodisponibilidad | |
WO2007137083A3 (en) | Injection device and method of assembly and activation | |
EA200300999A1 (ru) | Хронотерапевтические дозированные формы | |
BRPI0507530A (pt) | preparação para liberação prolongada, agente para evitar ou tratar doença, processo para produzir a preparação para liberação prolongada, método para evitar ou tratar doença, e, uso da preparação para liberação prolongada | |
SG159524A1 (en) | High yield spray application | |
PL1582620T3 (pl) | Żelazko do prasowania zawierające zbiornik na środek dodatkowy | |
AR044062A1 (es) | Una composicion que comprende un polimero cationico para mejorar la deposicion superficial | |
ATE433662T1 (de) | Mikroverkapselte agrochemische zusammensetzung | |
FR2813540B1 (fr) | Dispositif de pulverisation, notamment a usage agricole | |
BR0213220A (pt) | Processo de preparação de compostos de interação de uma substância ativa pouco solúvel em um meio aquoso com um suporte poroso, e, composto de interação de interação de uma substância ativa pouco solúvel em um meio aquoso em um suporte aquoso | |
WO2002032395A3 (en) | Sustained release delivery system and uses thereof | |
WO2004009164A3 (fr) | Dispositif d’injection d’un produit, notamment a usage medical | |
NO20024363D0 (no) | Nye LHRH-antagonister, produksjon og anvendelse av disse som medikamant | |
PT1006997E (pt) | Microsferas efervescentes e seu processo de fabrico | |
NO981186D0 (no) | Vandige lösninger av maursyre, propionsyre og ammoniakk, samt anvendelse av disse | |
DE60202488D1 (de) | Betätigungskappe zur radialen anordnung einer dose in einer haltevorrichtung | |
MXPA03001874A (es) | Metodo para remover proteina de articulos de caucho de latex sumergidos. | |
WO2003030867A3 (fr) | Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique | |
GB2370286A (en) | Pesticide protective articles | |
RU99127483A (ru) | Способ бальзамирования анатомических препаратов силоксановыми композициями | |
WO2004112947A3 (en) | Fluid system for conduit expansion and mobile arrangement therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |